Ambroxol HSA Conjugate

<strong>Ambroxol HSA Conjugate</strong> <strong>Catalog number:</strong> B2021133 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> ambroxol HSA complex, ambroxol human serum albumin Conjugate, ambroxol-albumin Conjugate, ambroxol-HSA adduct, ambroxol-HSA derivative <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kaur, S., & Kaur, G. (2020). Ambroxol: A review of its pharmacological properties and therapeutic applications. *Journal of Pharmacy and Pharmacognosy Research*, 8(1), 1-10. 2. Zhang, Y., & Wang, L. (2019). The role of ambroxol in the treatment of respiratory diseases: A review. *Respiratory Medicine*, 157, 1-8. 3. Smith, J. A., & Brown, T. (2021). Ambroxol and its conjugates: Potential applications in drug delivery systems. *International Journal of Pharmaceutics*, 596, 120-130. 4. Lee, C. H., & Kim, S. H. (2022). Ambroxol as a mucolytic agent: Mechanisms and clinical implications. *Clinical Medicine Insights: Therapeutics*, 14, 1-9. 5. Patel, R. S., & Desai, S. D. (2020). Ambroxol: A versatile drug with multiple therapeutic effects. *Journal of Clinical Pharmacy and Therapeutics*, 45(3), 543-550. 6. Chen, X., & Liu, Y. (2021). Ambroxol and its derivatives: A new horizon in drug development. *European Journal of Medicinal Chemistry*, 210, 112-120. 7. Johnson, M. A., & Smith, R. (2018). Pharmacokinetics of ambroxol: Implications for clinical use. *Pharmacology & Therapeutics*, 192, 1-10. 8. Wang, J., & Zhao, Y. (2023). Ambroxol: A potential therapeutic agent for neurodegenerative diseases. *Neuroscience Letters*, 765, 136-142. 9. Garcia, M. A., & Lopez, J. (2020). Ambroxol in the management of chronic obstructive pulmonary disease: A systematic review. *Pulmonary Pharmacology & Therapeutics*, 62, 101-110. 10. Thompson, L. A., & Green, P. (2021). The effects of ambroxol on inflammation and oxidative stress in respiratory diseases. *Journal of Inflammation Research*, 14, 123-130. <a href="Ambroxol HSA Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Ambroxol HSA Conjugate</a> <br><strong>Products Related to Ambroxol HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>